STOCK TITAN

Shorepower (NASDAQ: SPEV) to rebrand as Aeternum Health; 250M authorized shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
PRE 14C

Rhea-AI Filing Summary

Shorepower Technologies, Inc. notified stockholders that holders of approximately 52% of the voting power approved by written consent an amendment to change the company name to Aeternum Health, Inc. and to increase authorized common shares to 250,000,000.

The Information Statement states 59,290,204 shares of Common Stock and 2,000,000 shares of Series B Preferred Stock are outstanding as of the record date, with each Series B share voting as 40 shares of Common Stock. The amendment becomes effective on the later of a March date at least 20 days after mailing or the FINRA Daily List announcement.

Positive

  • None.

Negative

  • None.

Insights

Board and majority holder used written consent to approve a name change and large share authorization increase.

The filing discloses a written consent approved by holders controlling roughly 52% of Common Stock and all 2,000,000 Series B Preferred shares (each voting as 40 common shares), yielding the consenting stockholder control of 83% of Voting Stock.

This action was taken under Section 228 of Delaware law; timing for effectiveness ties to a March mailing threshold and FINRA listing notice. Subsequent public disclosures will show the official name and ticker in FINRA’s Daily List.

Amendment process and effective-date conditions are clearly stated; appraisal rights are not available.

The Certificate of Amendment increases authorized Common Stock to 250,000,000 and creates 10,000,000 shares of blank-check preferred stock; the Board retains authority to designate preferred series and terms.

The Information Statement notes Delaware law provides for written-consent action and that dissenters’ appraisal rights do not apply to these amendments.

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

SCHEDULE 14C

 

Information Statement Pursuant to Section 14(c) of the Securities

Exchange Act of 1934

Check the appropriate box:

 

Preliminary Information Statement
Confidential, for Use of the Commission Only (as permitted by Rule 14a-5(d)(2))
Definitive Information Statement

 

  SHOREPOWER TECHNOLOGIES, INC.
  (Name of Registrant as Specified in Its Charter)

 

 

  (Name of Person(s) Filing Proxy Statement, if other than the Registrant)

 

Payment of Filing Fee (Check the appropriate box):

 

No fee required.
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.

 

(1) Title of each class of securities to which transaction applies:
   
 

 

   
(2) Aggregate number of securities to which transaction applies:
   
 

 

   
(3) Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
   
 

 

   
(4) Proposed maximum aggregate value of transaction:
   
 

 

   
(5) Total fee paid:
   
 

 

 

Fee paid previously with preliminary materials.
   
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.

 

(1) Amount Previously Paid:
   
 

 

   
(2) Form, Schedule or Registration Statement No.:
   
 

 

   
(3) Filing Party:
   
 

 

   
(4) Date Filed:
   
   

 

 

 

 

 

 

SHOREPOWER TECHNOLOGIES, INC.

5289 NE Elam Young Pkwy.

Suite 180

Hillsboro, OR 97124

 

(509) 892-7345

 

Notice of Action by Written Consent of Shareholders to be Effective March __, 2026

 

Dear Stockholder:

 

Shorepower Technologies, Inc., a Delaware corporation. (the “Company”), hereby notifies our stockholders of record on February 27, 2026, that stockholders holding approximately 52% of the voting power have approved, by written consent in lieu of a special meeting on February 16, 2026, the following proposals:

 

Proposal 1: To change the name of the Company to Aeternum Health Inc.; and

 

Proposal 2: To increase the number of authorized shares of common stock to 250,000,000 shares of common stock.

 

This Information Statement is first being mailed to our stockholders of record as of the close of business on February 27, 2026. The action contemplated herein will not be effective until the later of (i) March __, 2026, a date which is at least 20 days after the date on which our definitive Information Statement is first mailed to our stockholders of record, or (ii) announcement of the Company’s new name and symbol in the Daily List by the Financial Industry Regulatory Authority (FINRA) of such corporate action. You are urged to read the Information Statement in its entirety for a description of the action taken by the majority stockholders of the Company.

 

WE ARE NOT ASKING YOU FOR A PROXY AND

YOU ARE REQUESTED NOT TO SEND US A PROXY.

 

The corporate action is taken by consent of the holders of a majority of the shares outstanding, and pursuant to Delaware law and the Company’s bylaws that permit holders of a majority of the voting power to take a stockholder action by written consent. Proxies are not being solicited because a stockholder holding approximately 52% of the issued and outstanding voting capital stock of the Company holds more than enough shares to effect the proposed action and has voted in favor of the proposals contained herein.

 

Exhibit A Amendment to the Company’s Certificate of Incorporation

 

/s/ Jeff Kim  
President and CEO’  
March __, 2026  

 

2

 

 

SHOREPOWER TECHNOLOGIES, INC.

 

5289 NE Elam Young Pkwy.

Suite 180

Hillsboro, OR 97124

 

INFORMATION STATEMENT

 

WE ARE NOT ASKING YOU FOR A PROXY AND YOU ARE REQUESTED NOT TO SEND US A PROXY.

 

General Information

 

This Information Statement is being furnished to the stockholders of Shorepower Technologies, Inc., a Delaware corporation (the “Company”), in connection with the adoption of an Amendment to our Certificate of Incorporation by written consent of our Board of Directors and the holders of a majority of our issued and outstanding voting securities in lieu of a special meeting. On February 16, 2026, both our Board of Directors approved and the holders of a majority of our voting capital stock approved an amendment to our Certificate of Incorporation to change our name to Aeternum Health, Inc. (the “Amendment”) and to increase the number of authorized shares of our common stock from 100,000,000 to 250,000,000. The Amendment has been filed with the Delaware Secretary of State but will not become effective until the later of (i) March __, 2026, a date which is at least 20 days after the date on which our definitive Information Statement is first mailed to our stockholders of record, or (ii) announcement of the Company’s new name and symbol in the Daily List by the Financial Industry Regulatory Authority (FINRA) of such corporate action.

 

Voting Securities

 

As of the date of this Information Statement, our voting securities consist of our shares of our common stock, par value $0.01 per share (“Common Stock”) of which 59,290,204 shares are outstanding, and 2,000,000 shares of Series B preferred stock, par value $0.01 (“Series B Preferred Stock”, and collectively with the Common Stock, the “Voting Stock”) that vote on an as-converted basis of 40 shares of Common Stock for each share of Series B preferred stock. Approval of the Amendment requires the affirmative consent of a majority of the shares of our Voting Stock issued and outstanding at February 27, 2026 (the “Record Date”). The quorum necessary to conduct business of the stockholders consists of a majority of the Voting Stock issued and outstanding as of the Record Date.

 

A stockholder who beneficially owns approximately 52% of the issued and outstanding shares of Common Stock and an aggregate of 2,000,000 shares of our Series B Preferred Stock is the “Consenting Stockholder.” Each holder of Series B Preferred Stock is entitled to cast 40 shares of Common Stock for each share of Series B Preferred Stock held. All 2,000,000 shares of Series B Preferred Stock are held by Jeff Kim, our current Chairman, President and CEO. The Consenting Stockholder has the power to vote 83% of our Voting Stock, which number exceeds the majority of the Voting Stock on the date of this Information Statement. The Consenting Stockholder has consented to the proposed action set forth herein and had and has the power to pass the proposed corporate action without the concurrence of any of our other stockholders.

 

The approval of this action by written consent is made possible by Section 228 of the Delaware General Corporation Law, which provides that the written consent of the holders of outstanding shares of voting stock, having not less than the minimum number of votes that would be necessary to authorize or take such action at a meeting at which all shares entitled to vote thereon were present and voted, may be substituted for such a meeting. To eliminate the costs involved in holding a special meeting, our Board of Directors elected to utilize the written consent of the holders of more than a majority of our voting securities.

 

This Information Statement will be mailed on or about March __, 2026 to stockholders of record as of the Record Date and is being delivered to inform you of the corporate action described herein before such action takes effect in accordance with Rule 14c-2 of the Securities Exchange Act of 1934.

 

The entire cost of furnishing this Information Statement will be borne by the Company. We will request brokerage houses, nominees, custodians, fiduciaries and other like parties to forward this Information Statement to the beneficial owners of our voting securities held of record by them, and we will reimburse such persons for out-of-pocket expenses incurred in forwarding such material.

 

3

 

 

Dissenters’ Right of Appraisal

 

The Delaware General Corporation Law does not provide for dissenter’s rights of appraisal in connection with the proposed action nor have we provided for appraisal rights in our Certificate of Incorporation or Bylaws.

 

PROPOSAL 1 –

AMENDMENT TO OUR CERTIFICATE OF INCORPORATION

TO EFFECT A CHANGE OF NAME OF THE COMPANY

 

We will change our name in an Amendment to our Certificate of Incorporation from “Shorepower Technologies, Inc.” to “Aeternum Health, Inc.” to reflect our new focus on developing services, products and solutions to increase longevity and achieve optimal health. Attached as Exhibit A and incorporated herein by reference is the text of the Certificate of Amendment to our Certificate of Incorporation as approved by the Consenting Stockholder to effect this change.

 

Certificate of Incorporation and Bylaws

 

Other provisions of the Company’s Certificate of Incorporation and Bylaws may have the effect of deterring unsolicited attempts to acquire a controlling interest in the Company or impeding changes in our management. Preferred stock may be issued in the future in connection with acquisitions, financings or other matters, as the Board of Directors deems appropriate. In the event that we determine to issue any shares of preferred stock, a certificate of designation containing the rights, privileges, and limitations of this series of preferred stock will be filed with the Secretary of State of the State of Delaware. The effect of this preferred stock designation power is that our Board of Directors alone, subject to Federal securities laws, applicable blue sky laws, and Delaware law, may be able to authorize the issuance of preferred stock which could have the effect of delaying, deferring, or preventing a change in control of the Company without further action by our stockholders, and may adversely affect the voting and other rights of the holders of 1our Common Stock.

 

Our Certificate of Incorporation does not provide our stockholders with cumulative voting rights.

 

Our Bylaws provide that the President of the Company shall call a special meeting of shareholder. whenever so requested in writing by a majority of directors or by shareholders representing not less than twenty-five (25%) percent of the total number of shares of the issued and outstanding capital stock entitled to vote at said meeting, but since our Certificate of Incorporation delegates to the Board of Directors the power to make, alter, amend, change, add to or repeal the Bylaws, this power might be used to defeat stockholder actions that are favored by the holders of a majority of our outstanding voting securities.

 

We are not aware of any attempt to take control of the Company and are not presenting this proposal with the intent that it be utilized as a type of anti−takeover device. The proposal is being made at this time to make available a sufficient number of shares of Common Stock and Preferred Stock to meet the Company’s current potential obligations to issue Common Stock and to provide us with greater flexibility to issue shares for general corporate purposes that may be identified in the future.

 

VOTING SECURITIES AND PRINCIPAL STOCKHOLDERS

 

The following table sets forth, as of February 23, 2026, certain information concerning the beneficial ownership of Common Stock by (i) each person known by the company to be the owner of more than 5% of the outstanding Common Stock, (ii) each director, (iii) our executive officers, and (iv) all directors and executive officers as a group. In general, “beneficial ownership” includes those shares a director or executive officer has the power to vote or the power to transfer, and stock options and other rights to acquire Common Stock that are exercisable currently or become exercisable within 60 days. Except as indicated otherwise, the persons named in the table below have sole voting and investment power with respect to all shares shown as beneficially owned by them. The calculation of the percentage owned is based on 59,290,204 shares of Common Stock outstanding and 2,000,000 shares of Series B Preferred Stock with the voting power of 40 shares of Common Stock for each share of Series B Preferred Stock issued and outstanding.

 

Jeff Kim has voting control through his ownership of 26,589,758 shares of Common Stock and 2,000,000 shares of Series B Preferred Stock. Each share of Series B Preferred Stock entitles the holder to vote on all matters submitted to a vote of our shareholders with each share casting a vote equal to 40 shares of Common Stock.

 

4

 

 

Name and Address1  Amount and Nature
of Beneficial
Ownership
   Percentage of
Voting Power
 
Jeff Kim (2)   26,589,758    52%
All Officers and Directors as a Group (1)   106,589,7581    81.18%

 

(1) Unless otherwise indicated, the address of such individual is c/o the Company.

 

(2) Jeff Kim has voting control through his ownership of 2,000,000 shares of Series B Preferred Stock voting on an as-converted basis and his ownership of 26,589,758 shares of Common Stock. This chart reflects total Voting Stock equal to the issued and outstanding shares of Common Stock and Series B Preferred Stock for a total of 131,290,204 shares of Voting Stock.

 

PROPOSAL 2 - AMENDMENT TO OUR CERTIFICATE OF INCORPORATION
TO INCREASE THE NUMBER OF AUTHORIZED SHARES OF COMMON STOCK

 

Our Board of Directors unanimously approved and adopted, subject to stockholder approval, an amendment to our Certificate of Incorporation to increase the authorized shares of Common Stock from 100,000,000 to 250,000,000. Attached as Exhibit A and incorporated herein by reference is the text of the Certificate of Amendment to our Certificate of Incorporation as approved by the Consenting Stockholder to effect this change.

 

DELIVERY OF DOCUMENTS TO SECURITY HOLDERS SHARING AN ADDRESS

 

Only one Information Statement is being delivered to multiple security holders sharing an address unless the Company has received contrary instructions from one or more of its security holders. The Company undertakes to deliver promptly upon written or oral request a separate copy of the Information Statement to a security holder at a shared address to which a single copy of the documents was delivered and provide instructions as to how a security holder can notify the Company that the security holder wishes to receive a separate copy of the Information Statement.

 

Security holders sharing an address and receiving a single copy may request to receive a separate Information Statement at Shorepower Technologies, Inc., 5289 NE Elam Young Pkwy., Suite 180, Hillsboro, OR 97124. Security holders sharing an address can request delivery of a single copy of the Information Statement if they are receiving multiple copies may also request to receive a separate Information Statement at Shorepower Technologies, Inc, 5289 NE Elam Young Pkwy., Suite 180, Hillsboro, OR 97124, telephone: (509) 892-7345.

 

COMPLIANCE WITH SECTION 16(a) OF THE SECURITIES EXCHANGE ACT OF 1934

 

Section 16(a) of the Securities Exchange Act of 1934, as amended, requires that our directors and executive officers, and persons who own more than ten percent (10%) of our outstanding Common Stock, file with the Securities and Exchange Commission (the “SEC”) initial reports of ownership and reports of changes in ownership of Common Stock. Such persons are required by the SEC to furnish us with copies of all such reports they file. Specific due dates for such reports have been established by the SEC and we are required to disclose any failure to file reports by such dates. We believe that during the fiscal year ended December 31, 2024, all reports required to be filed pursuant to Section 16(a) were filed on a timely basis.

 

WHERE YOU CAN OBTAIN ADDITIONAL INFORMATION

 

We are required to file annual, quarterly and special reports, proxy statements and other information with the SEC. You may read and copy any document we file at the SEC’s public reference rooms at 100 F Street, N.E, Washington, D.C. 20549. You may also obtain copies of the documents at prescribed rates by writing to the Public Reference Section of the SEC at 100 F Street, N.E., Room 1580, Washington, D.C. 20549. Please call the SEC at 1-800-SEC-0330 for more information on the operation of the public reference rooms. Copies of our SEC filings are also available to the public from the SEC’s web site at www.sec.gov.

 

We will provide, upon request and without charge, to each shareholder receiving this Information Statement a copy of our filings with the SEC and other publicly available information. A copy of any public filing is also available, at no charge, by contacting Shorepower Technologies, Inc., 5289 NE Elam Young Pkwy., Suite 180, Hillsboro, OR 97124, telephone: (509) 892-7345.

 

Date: February 24, 2026 Shorepower Technologies, Inc.
   
  By Order of the Board of Directors
     
  By: /s/ Jeff Kim
    Jeff Kim
    President and CEO

 

5

 

 

Exhibit A

 

STATE OF DELAWARE

CERTIFICATE OF AMENDMENT TO

THE CERTIFICATE OF INCORPORATION

OF

SHOREPOWER TECHNOLOGIES, INC.

 

Shorepower Technologies, Inc. (the “Corporation”), a Delaware corporation, does hereby certify that the following amendment to the Corporation’s Certificate of Incorporation to change Paragraph First to change the name of the Corporation and Paragraph Fourth to increase the number of authorized shares of common stock has been duly adopted in accordance with the provisions of Sections 228 and 242 of the Delaware General Corporation Law, as follows:

 

FIRST: The name of the corporation is:

 

Aeternum Health, Inc.

 

FOURTH: The aggregate number of shares which the Corporation shall have authority to issue is 250,000,000 shares of common stock, $.01 par value per share (“Common Stock”), and 10,000,000 shares of blank check preferred stock, par value $.01 per share. The Board of Directors is hereby expressly authorized to provide, out of the unissued shares of preferred stock, for one or more series of preferred stock and, with respect to each such series, to fix the number of shares constituting such series and the designation of such series, the voting powers, if any, of the shares of such series, and the preferences and relative, participating, optional, or other special rights, if any, and any qualifications, limitations, or restrictions thereof, of the shares of such series. The powers, preferences and relative, participating, optional and other special rights of each series of preferred stock, and the qualifications, limitations or restrictions thereof, if any, may differ from those of any and all other series at any time outstanding.

 

The effective date of this amendment shall be immediately upon the later of (i) the announcement of the name and symbol change of the Company in the Daily List by the Financial Industry Regulatory Authority (FINRA) of such corporate action or (ii) the first mailing of the Company’s Definitive Schedule 14C Information Statement to the Company’s shareholders of record.

 

IN WITNESS WHEREOF, the Corporation has made the foregoing Amendment to the Certificate of Incorporation, and the President has hereunto set his hand as of the 25th day of February, 2026.

 

  SHOREPOWER TECHNOLOGIES, INC.
     
  By: /s/ Jeff Kim
    Jeff Kim, President

 

6

 

FAQ

What corporate actions did Shorepower (SPEV) approve?

Shorepower approved a name change and an increase in authorized shares. Stockholders holding about 52% approved changing the name to Aeternum Health, Inc. and increasing authorized Common Stock to 250,000,000 shares by written consent.

When will the name change and amendment become effective?

The amendment is effective on the later of two events. It becomes effective on the later of (i) a March date at least 20 days after mailing the definitive Information Statement and (ii) announcement of the new name and symbol in FINRA’s Daily List.

Who provided the voting consent to approve these changes?

A consenting stockholder controlled the necessary votes. A holder of approximately 52% of Common Stock plus 2,000,000 Series B Preferred shares (voting as 40 common shares each) consented, giving control of about 83% of Voting Stock.

How many shares are currently outstanding as of the record date?

Shares outstanding are stated in the Information Statement. There were 59,290,204 shares of Common Stock outstanding and 2,000,000 shares of Series B Preferred Stock as of the record date used for this filing.

Do stockholders have appraisal rights for these amendments?

No appraisal rights are available under the disclosed terms. The Information Statement states that Delaware law does not provide dissenter’s appraisal rights for the proposed action and none were provided in the charter or bylaws.
United States Basketball League Inc

OTC:SPEV

SPEV Rankings

SPEV Latest News

SPEV Latest SEC Filings

SPEV Stock Data

1.23M
23.10M
Specialty Retail
Consumer Cyclical
Link
United States
Hillsboro